Cadrenal Therapeutics

CVKD

2.0906.09% ( +0.120 )

Closed: Jul 30, 16:00:00 (EDT)

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Cadrenal Therapeutics(CVKD) predict that the EBIT is -2.514 M (+35.99%), Beat estimate;the EPS is -1.04 (+50.24%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

Revenue

TBA--

0.00B--

----

EBITExceed expectations

-0.00B35.99%

-0.00B13.44%

+0.00B22.55%

EPSExceed expectations

-1.0450.24%

-1.5127.75%

+0.470022.49%

ActualEstimateUnit: USD

ActualEstimateUnit: USD

ActualEstimateUnit: USD

ActualEstimateUnit: USD